Atara Biotherapeutics, Inc Share Price
NASDAQ: ATRAHealthcare
Live Atara Biotherapeutics, Inc Share Price Chart
O H L
Atara Biotherapeutics, Inc Performance Overview
Days Range
▼
$9.93Low
$9.96High
Markets Today
| Previous Close | $9.71 |
|---|---|
| Open | $9.96 |
| Volume | 7,788 |
| Day's Range | $9.93 - $9.96 |
| 52W Range | NA |
| Market Cap | $101.48 M |
Historical Performance
| 1M Returns | +11.35 |
|---|---|
| 3M Returns | -3.57 |
| 6M Returns | +94.20 |
| 1Y Returns | -19.55 |
| 5Y Returns | -97.58 |
| 10Y Returns | -97.97 |
Atara Biotherapeutics, Inc Fundamentals
| Market Cap | $101.48 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $120.77 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $37.98 M |
| Profit Margin | 27.07 |
| Market Cap | $101.48 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $120.77 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $37.98 M |
| Profit Margin | 27.07 |
Atara Biotherapeutics, Inc Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $98.15 M | $17.57 M | $3.45 M | $1.59 M | $516.00 K | $630.00 K |
| Gross Profit + | $77.71 M | $17.02 M | $3.34 M | $1.49 M | $392.00 K | $439.00 K |
| Operating Income | $38.80 M | $3.20 M | -$3.57 M | -$2.56 M | -$3.37 M | -$4.72 M |
| EBITDA | $40.60 M | $3.43 M | -$3.54 M | -$2.51 M | -$3.34 M | -$4.71 M |
| Interest Expense | -$1.02 M | -$972.00 K | -$909.00 K | -$894.00 K | -$830.00 K | -$191.00 K |
| Depreciation | $1.79 M | $236.00 K | $36.00 K | $49.00 K | $29.00 K | $14.00 K |
| Income Before Tax | $38.01 M | $2.39 M | -$4.28 M | -$3.41 M | -$4.14 M | -$4.83 M |
| Income Tax Expense | $0 | $3.00 K | $28.00 K | $0 | $0 | $1.00 K |
| Net Income + | $38.01 M | $2.39 M | -$4.30 M | -$3.41 M | -$4.14 M | -$4.83 M |
| Net Profit Margin | 38.73% | 13.58% | -124.62% | -213.54% | -803.29% | -767.3% |
Atara Biotherapeutics, Inc Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $1.00 K | $1.00 K | $1.00 K | $1.00 K | $1.00 K | $1.00 K |
| Reserve & Surplus | -$2.02 B | -$2.01 B | -$2.02 B | -$2.02 B | -$2.03 B | -$2.03 B |
| Non-Current Liabilities | $69.22 M | $57.38 M | $48.74 M | $43.81 M | $51.66 M | $51.17 M |
| Current Liabilities | $47.89 M | $14.56 M | $18.06 M | $14.92 M | $5.64 M | $6.85 M |
| Total Liabilities | $117.11 M | $71.94 M | $66.80 M | $58.74 M | $57.31 M | $58.02 M |
| Fixed Assets | $285.00 K | $176.00 K | $147.00 K | $73.00 K | $55.00 K | $41.00 K |
| Current Assets | $27.18 M | $24.77 M | $18.43 M | $12.21 M | $12.17 M | $13.53 M |
| Total Assets | $62.04 M | $36.90 M | $30.17 M | $20.23 M | $20.00 M | $21.02 M |
Atara Biotherapeutics, Inc Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $38.01 M | $2.39 M | -$4.30 M | -$3.41 M | -$4.14 M | -$4.83 M |
| Operating Cash Flow | -$28.14 M | -$7.32 M | -$9.79 M | -$5.70 M | -$3.07 M | -$3.34 M |
| Investing Cash Flow | $17.20 M | -$5.07 M | -$2.42 M | $8.44 M | $0 | -$6.63 M |
| Financing Cash Flow | -$250.00 K | $15.30 M | $1.05 M | -$3.00 K | $2.95 M | $4.83 M |
| Change in Cash | -$11.19 M | $2.92 M | -$11.16 M | $2.74 M | -$122.00 K | -$5.14 M |
Atara Biotherapeutics, Inc Peer Comparison
| Company | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|
 | $1.30B | -48.93% | 0.00 | NA | 0.00% |
Atara Biotherapeutics, Inc Return Calculator
The Atara Biotherapeutics, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$239
Invested Amount$10,000
Est. Returns$-9,761
About Atara Biotherapeutics, Inc
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
Popular Stocks
FAQs
What is the share price of Atara Biotherapeutics, Inc today?
Atara Biotherapeutics, Inc (ATRA) share price as of September 18, 2026 is $9.60. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Atara Biotherapeutics, Inc?
Yes, Indian Investors can invest in the Atara Biotherapeutics, Inc (ATRA) Share by opening an international trading account with Angel One.
How can I purchase Atara Biotherapeutics, Inc shares in India?
Purchasing Atara Biotherapeutics, Inc (ATRA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Atara Biotherapeutics, Inc (ATRA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Atara Biotherapeutics, Inc?
Yes, you can purchase fractional shares of Atara Biotherapeutics, Inc (ATRA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Atara Biotherapeutics, Inc?
The market capitalization of Atara Biotherapeutics, Inc on September 18, 2026, is $101.48 M.
In which sector Atara Biotherapeutics, Inc belongs?
Atara Biotherapeutics, Inc operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Atara Biotherapeutics, Inc stocks?
In order to invest in Atara Biotherapeutics, Inc (ATRA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
